The combination is synergistic because BPC-157 and TB-500 address complementary stages of the healing cascade: Phase 1, Inflammation (Days 1-5): TB-500 suppresses the inflammatory cytokine response while BPC-157 begins upregulating growth factor signaling at the injury site
Arch Toxicol Suppl 3:95110 Ellouk-Achard S, Levresse V, Martin C, Pham-Huy C, Dutertre-Catella H, Thevenin M, Warnet JM, Claude JR (1995) Ex vivo and in vitro models in acetaminophen hepatotoxicity studies
Shin, S., Shin, Y., Lee, H
3335, dated 1st October 2022
3rd-Party Lab Tested Every batch is independently tested for purity and quality
Reactive oxygen species (ROS) and cancer: role of antioxidative nutraceuticals